257 related articles for article (PubMed ID: 26416763)
1. The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence.
Maleszewska M; Vanchin B; Harmsen MC; Krenning G
Angiogenesis; 2016 Jan; 19(1):9-24. PubMed ID: 26416763
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
3. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of endothelial-mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease.
Vanchin B; Sol M; Gjaltema RAF; Brinker M; Kiers B; Pereira AC; Harmsen MC; Moonen JAJ; Krenning G
Sci Rep; 2021 Sep; 11(1):17764. PubMed ID: 34493753
[TBL] [Abstract][Full Text] [Related]
5. Fluid shear stress promotes osteoblast proliferation via the Gαq-ERK5 signaling pathway.
Bo Z; Bin G; Jing W; Cuifang W; Liping A; Jinglin M; Jin J; Xiaoyi T; Cong C; Ning D; Yayi X
Connect Tissue Res; 2016 Jul; 57(4):299-306. PubMed ID: 27115838
[TBL] [Abstract][Full Text] [Related]
6. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
Xu S; Xu Y; Yin M; Zhang S; Liu P; Koroleva M; Si S; Little PJ; Pelisek J; Jin ZG
Theranostics; 2018; 8(11):3007-3021. PubMed ID: 29896299
[No Abstract] [Full Text] [Related]
7. Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2.
Floris I; Descamps B; Vardeu A; Mitić T; Posadino AM; Shantikumar S; Sala-Newby G; Capobianco G; Mangialardi G; Howard L; Dessole S; Urrutia R; Pintus G; Emanueli C
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):664-74. PubMed ID: 25614281
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
10. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
[TBL] [Abstract][Full Text] [Related]
12. Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation.
Heinen A; Tzekova N; Graffmann N; Torres KJ; Uhrberg M; Hartung HP; Küry P
Glia; 2012 Nov; 60(11):1696-708. PubMed ID: 22821416
[TBL] [Abstract][Full Text] [Related]
13. Activated p53 suppresses the histone methyltransferase EZH2 gene.
Tang X; Milyavsky M; Shats I; Erez N; Goldfinger N; Rotter V
Oncogene; 2004 Jul; 23(34):5759-69. PubMed ID: 15208672
[TBL] [Abstract][Full Text] [Related]
14. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
16. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.
Tao T; Liu D; Liu C; Xu B; Chen S; Yin Y; Ang L; Huang Y; Zhang X; Chen M
Biochim Biophys Acta; 2014 Sep; 1839(9):858-65. PubMed ID: 25017995
[TBL] [Abstract][Full Text] [Related]
17. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.
Siddiqi FS; Majumder S; Thai K; Abdalla M; Hu P; Advani SL; White KE; Bowskill BB; Guarna G; Dos Santos CC; Connelly KA; Advani A
J Am Soc Nephrol; 2016 Jul; 27(7):2021-34. PubMed ID: 26534922
[TBL] [Abstract][Full Text] [Related]
18. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
19. Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol.
Kumar A; Kumar S; Vikram A; Hoffman TA; Naqvi A; Lewarchik CM; Kim YR; Irani K
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1936-42. PubMed ID: 23723375
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
Zhang Y; Tong T
Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]